---
title: ExperTrials vs ProPharma Group
slug_a: expertrials
slug_b: propharmagroup
site: cro
review_signal_gate: closed
canonical_path: /compare/expertrials/propharmagroup
---

# ExperTrials vs ProPharma Group

Side-by-side profile data from each company listing on this directory.

## ExperTrials

- Profile: [/companies/expertrials](/companies/expertrials)

ExperTrials — European-based full-service CRO supporting biotech and medtech companies from Phase I through Phase IV and market access, with 80+ senior clinical research associates across Europe and the USA.

Services: 12. Modalities: 0. Indications: 6. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- EU EMA Regulatory Strategy
- Device & Combination Product Services

### Modalities

- Data not yet provided.

### Indications

- Oncology
- Neurology
- Cardiovascular
- Infectious Disease
- Rare Disease
- Gastroenterology

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## ProPharma Group

- Profile: [/companies/propharmagroup](/companies/propharmagroup)

ProPharma Group — ProPharma Group provides pharmacovigilance, regulatory sciences, medical information, medical writing, and biostatistics services to life sciences companies. Its regulatory offering covers FDA and European work, including an AI-assisted capability for ANDA submission development.

Services: 7. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Clinical Operations
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Data not yet provided.

### Sourcing models

- Data not yet provided.